Hikma, Hikma Pharmaceuticals

Hikma stock after-hours at EUR 0.87: plus 2.35 percent after the Xetra close

Published on 09/30/2026 at 18:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Hikma stock traded after-hours at EUR 0.87, up 2.35 percent versus the prior close. Lang & Schwarz recorded the price at 6:01 p.m. CEST on September 30, 2026.

Fotorealistische sterile Pharma-Produktionslinie mit Injektionsfläschchen und Edelstahlanlagen
Hikma Pharmaceuticals PLC GB00B128J450 zeigt moderne Injektions-Produktionslinie in sterilem Pharmawerk mit Edelstahlanlagen, Illustration mit AI erstellt.

Hikma stock traded after-hours at EUR 0.87, up 2.35 percent versus the prior close of EUR 0.85 at Lang & Schwarz on September 29, 2026. The quote was recorded at 6:01 p.m. CEST on September 30, 2026.

Hikma names next chief financial officer

Hikma Pharmaceuticals PLC (LSE: HIK) said on September 24 that Rebecca Hall will become chief financial officer and an executive director in the first quarter of 2027. She will replace Khalid Nabilsi, who is scheduled to leave the board on December 31, 2026, while continuing as deputy CEO for North America and Europe. Hikma

R&D investor seminars scheduled

On September 22, Hikma announced three educational investor seminars covering its R&D strategy and capabilities. The sessions are scheduled for October 20, November 24 and December 16, 2026. Hikma said the seminars will not provide new material financial or trading information, and that its next scheduled trading update is due on November 5. Hikma

Disclaimer...

en | boerse | 70205410 |